+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nerve Repair and Regeneration Devices - Global Strategic Business Report

  • PDF Icon

    Report

  • 510 Pages
  • February 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 4805293
The global market for Nerve Repair and Regeneration Devices was valued at US$9.7 Billion in 2024 and is projected to reach US$17.6 Billion by 2030, growing at a CAGR of 10.5% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Nerve Repair and Regeneration Devices Market - Key Trends & Drivers Summarized

Nerve repair and regeneration devices are crucial in the field of neurology and neurosurgery, providing innovative solutions for the treatment of nerve injuries and disorders. These devices aim to restore function and facilitate the regeneration of damaged nerves, which is critical for patients suffering from conditions such as peripheral nerve injuries, spinal cord injuries, and neuropathies. Nerve repair devices include nerve conduits, nerve wraps, and nerve grafts, which are used to bridge gaps in damaged nerves and promote natural healing processes. On the other hand, nerve regeneration technologies focus on stimulating nerve growth and repair through advanced biomaterials, growth factors, and cellular therapies. These devices and technologies play a vital role in improving patient outcomes, reducing recovery times, and enhancing the quality of life for individuals with nerve damage.

Technological advancements have significantly impacted the development and efficacy of nerve repair and regeneration devices. Innovations in biomaterials have led to the creation of more biocompatible and durable nerve conduits and grafts, which support the natural healing process while minimizing the risk of rejection and complications. The integration of growth factors and stem cells into nerve regeneration therapies has shown promising results in stimulating nerve growth and repair, offering new hope for patients with severe nerve injuries. Additionally, advancements in 3D printing technology have enabled the production of customized nerve repair devices tailored to the specific needs of individual patients, improving the precision and effectiveness of treatments. Research in neurobiology and tissue engineering continues to drive the development of novel therapies and devices, pushing the boundaries of what are possible in nerve repair and regeneration.

The growth in the nerve repair and regeneration devices market is driven by several factors, including the increasing prevalence of nerve injuries, advancements in medical technology, and rising awareness about nerve repair treatments. The rapid rise in the incidence of nerve injuries worldwide, increasing prevalence of various neurological disorders, especially in the expanding elderly population, and development of advanced technology-based nerve repair and regeneration products are fueling market growth. The growing incidence of traumatic injuries, such as those resulting from accidents and sports activities, has led to a higher demand for effective nerve repair solutions. Additionally, the aging population is more susceptible to nerve damage due to degenerative conditions and chronic diseases, further driving market growth. Technological innovations have made nerve repair and regeneration devices more effective and accessible, with ongoing research leading to new and improved treatment options. Increased funding for neurological research and the development of advanced therapies are also contributing to market expansion. Furthermore, greater awareness among healthcare professionals and patients about the benefits of early intervention and advanced nerve repair techniques is boosting the adoption of these devices. As the healthcare industry continues to prioritize the treatment of nerve injuries and disorders, the demand for nerve repair and regeneration devices is expected to grow, spurring further advancements and innovations in this field.

Scope of the Study

The report analyzes the Nerve Repair and Regeneration Devices market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.

Segments:

Product (Neurostimulation & Neuromodulation Devices, and Biomaterials); Application (Neurostimulation & Neuromodulation Surgeries, Neurorrhaphy, Nerve Grafting, and Stem Cell Therapy); and End-Use (Hospitals & Clinics, and Ambulatory Surgery Centers).

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Neurostimulation & Neuromodulation Devices segment, which is expected to reach US$14.7 Billion by 2030 with a CAGR of a 10.1%. The Biomaterials segment is also set to grow at 12.2% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $2.9 Billion in 2024, and China, forecasted to grow at an impressive 13.3% CAGR to reach $2.9 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players such as Abbott Laboratories, Inc., Boston Scientific Corporation, Collagen Matrix, Inc., ERBE Elektromedizin GmbH, Inspire Medical Systems, Inc. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Nerve Repair and Regeneration Devices Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Nerve Repair and Regeneration Devices Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Nerve Repair and Regeneration Devices Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Some of the 61 major companies featured in this Nerve Repair and Regeneration Devices market report include:

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Collagen Matrix, Inc.
  • ERBE Elektromedizin GmbH
  • Inspire Medical Systems, Inc.
  • Aleva Neurotherapeutics SA
  • Biowave Corporation
  • Inomed Medizintechnik GmbH
  • Bioness Inc.
  • EMS Handels Gesellschaft mbH
  • Axonics Modulation Technologies, Inc.
  • Checkpoint Surgical Inc
  • BioArctic AB
  • Bovie Medical Corporation
  • Gimer Medical

Table of Contents

I. METHODOLOGYMII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Nerve Repair and Regeneration Market Set for a Robust Growth
  • Neurostimulation & Neuromodulation Devices Hold Commanding Slot in Nerve Repair & Regeneration Market
  • Biomaterials to Exhibit Rapid Growth
  • Nerve Repair and Regeneration Market by Application
  • US and Europe Dominate the Market
  • Asia-Pacific and other Emerging Regions Display Impressive Growth Potential
  • Competition
  • Nerve Repair and Regeneration Devices - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • High Incidence of Neurological Disorders: A Key Market Driver
  • Annual Incidence of Adult-Onset Neurologic Disorders in the US
  • Effects of COVID-19 on the Nervous System Sheds Focus on Neuromodulation Applications
  • Increasing Cases of Peripheral Nerve Injuries Drive the Nerve Repair and Regeneration Market
  • Growing Number of Vehicular Accidents Drive the Peripheral Nerve injuries Repair Market
  • Rising Geriatric Population and Subsequent Growth in Prevalence Of Neurological Disorders
  • Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Growing Incidence of Neurodegenerative Diseases Propels the Market for Deep Brain Stimulation Devices
  • Global Alzheimer's Prevalence by Age Group
  • Diagnosed Prevalence Cases of Parkinson’s Disease Across Select Countries
  • Select Available Deep Brain Stimulation Devices Available in the Market
  • Intensified Research Activity Across Various Neural Disciplines Induces Additional Optimism
  • Stem Cell Therapy: A Promising Avenue for Nerve Repair and Regeneration
  • Increasing Cases of Epilepsy Drives the Demand for Vagus Nerve Stimulation Devices
  • Spinal Cord Injuries Propel the Demand for Spinal Cord Stimulation Devices
  • Recent Developments in Spinal Cord Injury Treatment
  • Biomaterials (Nerve Conduits and Nerve Wraps) to Witness Rapid Growth
  • New Biomaterials Pave the Way for Innovative Neurodegeneration Therapies
  • Role of Nerve Conduits in the Treatment of Peripheral Nerve Injury
  • Innovative Nerve Conduits from Stryker
  • TENS (Transcutaneous electrical nerve stimulation devices) Market Witnesses Rapid Growth
  • Non-Invasiveness of TMS (Transcranial Magnetic Stimulation) Propelling the adoption of TMS devices
  • Nerve Grafts for Bridging Larger Nerve Gaps
  • Role of Nerve Grafting in Treatment of Peripheral Nerve Injuries
  • FDA-approved Nerve Tubes for Peripheral Nerve Repair
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Nerve Repair and Regeneration Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Nerve Repair and Regeneration Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 3: World 15-Year Perspective for Nerve Repair and Regeneration Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Neurostimulation & Neuromodulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Neurostimulation & Neuromodulation Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 6: World 15-Year Perspective for Neurostimulation & Neuromodulation Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Biomaterials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Biomaterials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 9: World 15-Year Perspective for Biomaterials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Neurostimulation & Neuromodulation Surgeries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Neurostimulation & Neuromodulation Surgeries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 12: World 15-Year Perspective for Neurostimulation & Neuromodulation Surgeries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Neurorrhaphy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Neurorrhaphy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 15: World 15-Year Perspective for Neurorrhaphy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Nerve Grafting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Nerve Grafting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 18: World 15-Year Perspective for Nerve Grafting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Stem Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Stem Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 21: World 15-Year Perspective for Stem Cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 23: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 24: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 25: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 26: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 27: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 28: World Nerve Repair and Regeneration Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Nerve Repair and Regeneration Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
CANADA
JAPAN
  • Nerve Repair and Regeneration Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
CHINA
  • Nerve Repair and Regeneration Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
EUROPE
  • Nerve Repair and Regeneration Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
FRANCE
  • Nerve Repair and Regeneration Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
GERMANY
  • Nerve Repair and Regeneration Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
ITALY
UNITED KINGDOM
  • Nerve Repair and Regeneration Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Nerve Repair and Regeneration Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
AUSTRALIA
  • Nerve Repair and Regeneration Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
INDIA
  • Nerve Repair and Regeneration Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Nerve Repair and Regeneration Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Nerve Repair and Regeneration Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Nerve Repair and Regeneration Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories, Inc.
  • Boston Scientific Corporation
  • Collagen Matrix, Inc.
  • ERBE Elektromedizin GmbH
  • Inspire Medical Systems, Inc.
  • Aleva Neurotherapeutics SA
  • Biowave Corporation
  • Inomed Medizintechnik GmbH
  • Bioness Inc.
  • EMS Handels Gesellschaft mbH
  • Axonics Modulation Technologies, Inc.
  • Checkpoint Surgical Inc
  • BioArctic AB
  • Bovie Medical Corporation
  • Gimer Medical

Table Information